Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 1, 2017 - Issue 2
Journal homepage
127
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Crizotinib may be effective for rheumatoid arthritis: a case report of a rheumatoid arthritis patient with lung cancer

Shuichiro NakaboDepartment of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; ;Shin-Kawabata Hospital, Nagaokakyo, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9250-1851
ORCID Icon,
Fumiaki GochiDepartment of Thoracic Surgery, Respiratory Disease Center, Kyoto Katsura Hospital, Kyoto, Japan;
,
Yumiko YasuharaDepartment of Diagnostic Pathology, Kyoto Katsura Hospital, Kyoto, Japan
&
Yasuji TeradaDepartment of Thoracic Surgery, Respiratory Disease Center, Kyoto Katsura Hospital, Kyoto, Japan;
Pages 49-53 | Received 20 Dec 2016, Accepted 23 Feb 2017, Published online: 16 Mar 2017

References

  • Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75:3–15.
  • Smolen JS, Aletaha D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat Rev Rheumatol. 2015;11:276–289.
  • Kalden JR. Emerging therapies for rheumatoid arthritis. Rheumatol Ther. 2016;3:31–42.
  • Sanseau P, Agarwal P, Barnes MR, et al. Use of genome-wide association studies for drug repositioning. Nat Biotechnol. 2012;30:317–320.
  • Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506:376–381.
  • Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010;363:1693–1703.
  • Sakamoto H, Tsukaguchi T, Hiroshima S, et al. CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant. Cancer Cell. 2011;19:679–690.
  • Zou HY, Li Q, Lee JH, et al. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res. 2007;67:4408–4417.
  • Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251:802–804.
  • Naldini L, Vigna E, Narsimhan RP, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene. 1991;6:501–504.
  • Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 1991;6:1997–2003.
  • Maroun CR, Rowlands T. The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance. Pharmacol Ther. 2014;142:316–338.
  • Ilangumaran S, Villalobos-Hernandez A, Bobbala D, et al. The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: diverse roles in modulating immune cell functions. Cytokine. 2016;82:125–139.
  • Koch AE, Halloran MM, Hosaka S, et al. Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum. 1996;39:1566–1575.
  • Shibasaki S, Tsunemi S, Kitano S, et al. Differential regulation of c-Met signaling pathways for synovial cell function. Springerplus. 2014;3:554.
  • Yukioka K, Inaba M, Furumitsu Y, et al. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells. J Rheumatol. 1994;21:2184–2189.
  • Feuerherm AJ, Borset M, Seidel C, et al. Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scand J Rheumatol. 2001;30:229–234.
  • Hashimoto N, Iwasaki T, Kitano M, et al. Levels of vascular endothelial growth factor and hepatocyte growth factor in sera of patients with rheumatic diseases. Mod Rheumatol. 2003;13:129–134.
  • Grandaunet B, Syversen SW, Hoff M, et al. Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 2011;63:662–669.
  • Molnarfi N, Benkhoucha M, Funakoshi H, et al. Hepatocyte growth factor: a regulator of inflammation and autoimmunity. Autoimmun Rev. 2015;14:293–303.
  • Okunishi K, Dohi M, Fujio K, et al. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol. 2007;179:5504–5513.
  • Tsunemi S, Iwasaki T, Kitano S, et al. Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis. Arthritis Res Ther. 2013;15:R75.
  • Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16:553–572.
  • Solomon BJ, Mok T, Kim DW, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371:2167–2177.
  • Sakai K, Aoki S, Matsumoto K. Hepatocyte growth factor and Met in drug discovery. J Biochem. 2015;157:271–284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.